Herbaspirillum species, an organism commonly found in soil, has only recently been linked to disease in humans. We report Herbaspirillum bacteremia in a 2-year-old female patient following a hematopoietic stem cell transplant for relapsed acute lymphoblastic leukemia.
CASE REPORTWe report the case of a 2-year-old female diagnosed with acute lymphoblastic leukemia (ALL) classified as high-risk due to MLL gene rearrangement. A double-lumen Broviac catheter was placed for intravascular access. The child went into clinical remission after standard five-drug induction chemotherapy, but cytogenetic analysis of her bone marrow following induction revealed the presence of persistent leukemic cells, conferring a risk for relapse. As a result, she underwent a matched, unrelated donor hematopoietic stem cell transplant (MUD HSCT). The child's course of treatment was uncomplicated until posttransplant day 162, when she was admitted with a 2-day history of fever (maximum temperature, 103.5°F) and diarrhea. She presented to her local hospital emergency room, where she was found to be tachycardic and febrile. She received two intravenous normal saline fluid boluses and was empirically started on ceftriaxone (50 mg/kg of body weight) prior to transfer to our hospital.On admission, the patient was hemodynamically stable, with an unremarkable physical examination. Admission laboratory results included a white blood cell (WBC) count of 3,400/mm 3 , with 83% neutrophils, 1% bands, 11% lymphocytes, 5% monocytes, an absolute neutrophil count of 2,822, and a hemoglobin level of 9.5 g/dl. She was empirically started on cefepime (50 mg/kg) administered every 8 h. Given the history of diarrhea, stool was sent for enteric culture and Clostridium difficile toxin testing. These studies were negative, and the child's diarrhea resolved spontaneously on admission.Isolator blood cultures were drawn on admission from both the red and the white central venous line lumens, and within 36 h, the quantity (CFU/ml) of a long, thin, oxidasepositive, weakly catalase-positive, Gram-negative bacillus was too numerous to count. At this point, gentamicin (2.5 mg/kg/dose every 8 h) was added to the antibiotic therapy.Two days later, an Isolator blood culture from the white lumen was still growing the same organism in a quantity too numerous to count, while 39 CFU/ml was recovered from the red lumen. Blood cultures drawn on the third day from both central venous line lumens and a peripheral site were sterile. Antibiotic therapy was changed to meropenem at a dose of 20 mg/kg every 8 h for a total of 7 days following the negative blood culture.The Vitek 2 Gram-negative identification system identified the organism as Burkholderia cepacia complex. The corresponding Kirby-Bauer disk diffusion susceptibility testing showed that the isolate was colistin resistant (consistent with B. cepacia) but susceptible to piperacillin-tazobactam, ticarcillinclavulanic acid, trimethoprim-sulfamethoxazole, meropenem, ceftazidime, gentamicin, amikacin, tobramycin, ciprofloxacin, ...